Publications

Causal effects of stochastic PrEP interventions on HIV incidence among men who have sex with men.

Am J Epidemiol
Sewak A, Lodi S, Li X, Shu D, Wen L, Mayer KH, Krakower DS, Young JG, Marcus JL

Intervention treatment distributions that depend on the observed treatment process and model double robustness in causal survival analysis.

Stat Methods Med Res
Wen L, Marcus JL, Young JG

Using Health Care Professionals' Perspectives to Refine a Clinical Decision Support Implementation Strategy for Increasing the Prescribing of HIV Preexposure Prophylaxis (PrEP) in Alabama.

J Int Assoc Provid AIDS Care
Humphries DL, Rhodes EC, Simon CL, Wang V, Spiegelman D, Ott C, Hicks D, Marcus JL, Krakower D, Rana A

Correlations between community-level HIV preexposure prophylaxis coverage and individual-level sexual behaviors among United States MSM

Mann, Laura M.; Le Guillou, Adrien; Goodreau, Steven M; Marcus, Julia L; Sanchez, Travis; Weiss, Kevin M.; Jenness, Samuel M.

Development of an HIV Risk Prediction Model Using Electronic Health Record Data from an Academic Health System in the Southern United States.

Clin Infect Dis
Burns CM, Pung L, Witt D, Gao M, Sendak M, Balu S, Krakower D, Marcus JL, Okeke NL, Clement ME

Competing health risks associated with the COVID-19 pandemic and early response: A scoping review

HIV Prevention and the 340B Drug Pricing Program. Reply.

N Engl J Med
Marcus JL, Killelea A, Krakower DS

Perverse Incentives - HIV Prevention and the 340B Drug Pricing Program.

N Engl J Med
Marcus JL, Killelea A, Krakower DS

Making PrEP easy.

Lancet HIV
Marcus JL, Krakower DS

What has the pandemic revealed about the shortcomings of modern epidemiology? What can we fix or do better?

Am J Epidemiol
Dimitris MC, Galea S, Marcus JL, Pan A, Sander B, Platt RW

Preferences for HIV Preexposure Prophylaxis Products Among Black Women in the U.S.

AIDS Behav
Irie WC, Calabrese SK, Patel RR, Mayer KH, Geng EH, Marcus JL

Hepatitis C coinfection and extrahepatic cancer incidence among people living with HIV

HIV Med
Willis SJ, Kim HN, Achenbach CJ, et al.

Cannabis Use and Patient-Centered Care During Pregnancy and Post Partum Among People Living With HIV

JAMA Netw Open
Young-Wolff KC, Marcus JL, Satre DD.

The HIV preexposure prophylaxis (PrEP) continuum of care among transgender individuals in an integrated healthcare system.

J Acquir Immune Defic Syndr
Hojilla JC, Hurley LB, Marcus JL, Satre DD, Silverberg MJ, Zaritsky EF, Getahun D, Goodman M, Volk JE

Cancer in people with and without hepatitis C virus infection: comparison of risk before and after introduction of direct-acting antivirals.

Cancer Epidemiol Biomarkers Prev
Lam JO, Hurley LB, Lai JB, Saxena V, Seo S, Chamberland S, Quesenberry CP, Champsi JH, Ready J, Chiao EY, Marcus JL, Silverberg MJ

Characterization of HIV Preexposure Prophylaxis Use Behaviors and HIV Incidence Among US Adults in an Integrated Health Care System.

JAMA Netw Open
Hojilla JC, Hurley LB, Marcus JL, Silverberg MJ, Skarbinski J, Satre DD, Volk JE

Brief Report: "I Didn't Really Have a Primary Care Provider Until I Got PrEP": Patients' Perspectives on HIV Preexposure Prophylaxis as a Gateway to Health Care.

J Acquir Immune Defic Syndr
Sewell WC, Powell VE, Ball-Burack M, Mayer KH, Ochoa A, Marcus JL, Krakower DS

Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide for Human Immunodeficiency Virus Preexposure Prophylaxis at a Boston Community Health Center.

Open Forum Infect Dis
Marcus JL, Levine K, Sewell WC, Solleveld P, Mayer KH, Krakower DS

Brief Report: HIV Pre-Exposure Prophylaxis Prescribing in an Urban Safety-Net Health System.

J Acquir Immune Defic Syndr
Manza-A Agovi A, Anikpo I, Cvitanovich M, Fasanmi EO, Ojha RP, Marcus JL

A decision analytics model to optimize investment in interventions targeting the HIV PrEP cascade of care.

AIDS
Jenness SM, Knowlton G, Smith DK, Marcus JL, Anderson EJ, Siegler AJ, Jones J, Sullivan PS, Enns E